AAAAAA

   
Results: 1-17 |
Results: 17
DIRECT-INJECTION OF Y-90 MOABS INTO GLIOMA TUMOR RESECTION CAVITIES LEADS TO LIMITED DIFFUSION OF THE RADIOIMMUNOCONJUGATES INTO NORMAL BRAIN PARENCHYMA - A MODEL TO ESTIMATE ABSORBED RADIATION-DOSE
Authors: HOPKINS K CHANDLER C EATOUGH J MOSS T KEMSHEAD JT
Citation: K. Hopkins et al., DIRECT-INJECTION OF Y-90 MOABS INTO GLIOMA TUMOR RESECTION CAVITIES LEADS TO LIMITED DIFFUSION OF THE RADIOIMMUNOCONJUGATES INTO NORMAL BRAIN PARENCHYMA - A MODEL TO ESTIMATE ABSORBED RADIATION-DOSE, International journal of radiation oncology, biology, physics, 40(4), 1998, pp. 835-844
TREATMENT OF NEOPLASTIC MENINGITIS BY TARGETED RADIATION USING I-131 RADIOLABELED MONOCLONAL-ANTIBODIES - RESULTS OF RESPONSES AND LONG-TERM FOLLOW-UP IN 40 PATIENTS
Authors: COAKHAM HB KEMSHEAD JT
Citation: Hb. Coakham et Jt. Kemshead, TREATMENT OF NEOPLASTIC MENINGITIS BY TARGETED RADIATION USING I-131 RADIOLABELED MONOCLONAL-ANTIBODIES - RESULTS OF RESPONSES AND LONG-TERM FOLLOW-UP IN 40 PATIENTS, Journal of neuro-oncology, 38(2-3), 1998, pp. 225-232
DOSE-ESCALATION WITH REPEATED INTRATHECAL INJECTIONS OF I-131-LABELEDMABS FOR THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM MALIGNANCIES
Authors: KEMSHEAD JT HOPKINS K PIZER B PAPANASTASSIOU V COAKHAM H BULLIMORE J CHANDLER C
Citation: Jt. Kemshead et al., DOSE-ESCALATION WITH REPEATED INTRATHECAL INJECTIONS OF I-131-LABELEDMABS FOR THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM MALIGNANCIES, British Journal of Cancer, 77(12), 1998, pp. 2324-2330
THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT
Authors: CASTLEBERRY RP PRITCHARD J AMBROS P BERTHOLD F BRODEUR GM CASTEL V COHN SL DEBERNARDI B DICKSMIREAUX C FRAPPAZ D HAASE GM HABER M JONES DR JOSHI VV KANEKO M KEMSHEAD JT KOGNER P LEE REJ MATTHAY KK MICHON JM MONCLAIR R ROALD BR SEEGER RC SHAW PJ SHIMADA H SHUSTER JJ
Citation: Rp. Castleberry et al., THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT, European journal of cancer, 33(12), 1997, pp. 2113-2116
SUBLETHAL EFFECTS OF EXPOSING THE HUMAN-MELANOMA CELL-LINE SKMEL-23 TO 532 NM LASER-LIGHT
Authors: ZHU NW KENEALY J BURD A GRADIDGE T WARR R RIGBY HS KEMSHEAD JT
Citation: Nw. Zhu et al., SUBLETHAL EFFECTS OF EXPOSING THE HUMAN-MELANOMA CELL-LINE SKMEL-23 TO 532 NM LASER-LIGHT, International journal of cancer, 72(6), 1997, pp. 1104-1112
A MODEL TO ESTIMATE THE DOSE TO TUMOR FOLLOWING INTRACAVITY ADMINISTRATION OF RADIOIMMUNOCONJUGATES TO PATIENTS WITH MALIGNANT GLIOMAS
Authors: HOPKINS K PAPANASTASSIOU V ZANANIRI FAF KEMSHEAD JT
Citation: K. Hopkins et al., A MODEL TO ESTIMATE THE DOSE TO TUMOR FOLLOWING INTRACAVITY ADMINISTRATION OF RADIOIMMUNOCONJUGATES TO PATIENTS WITH MALIGNANT GLIOMAS, British journal of radiology, 70(839), 1997, pp. 1152-1161
L1 ADHESION MOLECULE ON HUMAN-LYMPHOCYTES AND MONOCYTES - EXPRESSION AND INVOLVEMENT IN BINDING TO ALPHA-V-BETA-3 INTEGRIN
Authors: EBELING O DUCZMAL A AIGNER S GEIGER C SCHOLLHAMER S KEMSHEAD JT MOLLER P SCHWARTZALBIEZ R ALTEVOGT P
Citation: O. Ebeling et al., L1 ADHESION MOLECULE ON HUMAN-LYMPHOCYTES AND MONOCYTES - EXPRESSION AND INVOLVEMENT IN BINDING TO ALPHA-V-BETA-3 INTEGRIN, European Journal of Immunology, 26(10), 1996, pp. 2508-2516
THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN GLIOBLASTOMA - GENOMIC AMPLIFICATION, PROTEIN EXPRESSION, AND PATIENT SURVIVAL-DATA IN A THERAPEUTIC TRIAL
Authors: SCHOBER R BILZER T WAHA A REIFENBERGER G WECHSLER W VONDEIMLING A WIESTLER OD WESTPHAL M KEMSHEAD JT VEGA F DELATTRE JY STASIECKISTEINFELD P
Citation: R. Schober et al., THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN GLIOBLASTOMA - GENOMIC AMPLIFICATION, PROTEIN EXPRESSION, AND PATIENT SURVIVAL-DATA IN A THERAPEUTIC TRIAL, Clinical neuropathology, 14(3), 1995, pp. 169-174
PHARMACOKINETICS AND DOSE ESTIMATES FOLLOWING INTRATHECAL ADMINISTRATION OF I-131 MONOCLONAL-ANTIBODIES FOR THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM MALIGNANCIES
Authors: PAPANASTASSIOU V PIZER BL CHANDLER CL ZANANIRI TF KEMSHEAD JT HOPKINS KI
Citation: V. Papanastassiou et al., PHARMACOKINETICS AND DOSE ESTIMATES FOLLOWING INTRATHECAL ADMINISTRATION OF I-131 MONOCLONAL-ANTIBODIES FOR THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM MALIGNANCIES, International journal of radiation oncology, biology, physics, 31(3), 1995, pp. 541-552
A PILOT-STUDY OF THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WITH INTRATUMORAL Y-90 RADIOIMMUNOCONJUGATES
Authors: HOPKINS K CHANDLER C BULLIMORE J SANDEMAN D COAKHAM H KEMSHEAD JT
Citation: K. Hopkins et al., A PILOT-STUDY OF THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WITH INTRATUMORAL Y-90 RADIOIMMUNOCONJUGATES, Radiotherapy and oncology, 34(2), 1995, pp. 121-131
THE POTENTIAL OF TARGETED RADIOTHERAPY IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM LEUKEMIA
Authors: PIZER BL KEMSHEAD JT
Citation: Bl. Pizer et Jt. Kemshead, THE POTENTIAL OF TARGETED RADIOTHERAPY IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM LEUKEMIA, Leukemia & lymphoma, 15(3-4), 1994, pp. 281-289
THE POTENTIAL OF TARGETED RADIOTHERAPY IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM LEUKEMIA
Authors: PIZER BL KEMSHEAD JT
Citation: Bl. Pizer et Jt. Kemshead, THE POTENTIAL OF TARGETED RADIOTHERAPY IN THE TREATMENT OF CENTRAL-NERVOUS-SYSTEM LEUKEMIA, Leukemia & lymphoma, 15(3-4), 1994, pp. 281-289
TISSUE-SPECIFIC EXPRESSION OF NEURAL CELL-ADHESION MOLECULE (NCAM) MAY ALLOW DIFFERENTIAL-DIAGNOSIS OF NEUROBLASTOMA FROM EMBRYONAL RHABDOMYOSARCOMA
Authors: PHIMISTER EG CULVERWELL A PATEL K KEMSHEAD JT
Citation: Eg. Phimister et al., TISSUE-SPECIFIC EXPRESSION OF NEURAL CELL-ADHESION MOLECULE (NCAM) MAY ALLOW DIFFERENTIAL-DIAGNOSIS OF NEUROBLASTOMA FROM EMBRYONAL RHABDOMYOSARCOMA, European journal of cancer, 30A(10), 1994, pp. 1552-1558
TISSUE-SPECIFIC EXPRESSION OF NEURAL CELL-ADHESION MOLECULE (NCAM) MAY ALLOW DIFFERENTIAL-DIAGNOSIS OF NEUROBLASTOMA FROM EMBRYONAL RHABDOMYOSARCOMA
Authors: PHIMISTER EG CULVERWELL A PATEL K KEMSHEAD JT
Citation: Eg. Phimister et al., TISSUE-SPECIFIC EXPRESSION OF NEURAL CELL-ADHESION MOLECULE (NCAM) MAY ALLOW DIFFERENTIAL-DIAGNOSIS OF NEUROBLASTOMA FROM EMBRYONAL RHABDOMYOSARCOMA, European journal of cancer, 30A(10), 1994, pp. 1552-1558
TOPOGRAPHY OF NCAM ANTIGENIC EPITOPES RECOGNIZED BY SCLC-CLUSTER-1 ANTIBODIES - A CONSENSUS VIEW
Authors: GERARDYSCHAHN R ECKHARDT M LEDERMANN J KEMSHEAD JT
Citation: R. Gerardyschahn et al., TOPOGRAPHY OF NCAM ANTIGENIC EPITOPES RECOGNIZED BY SCLC-CLUSTER-1 ANTIBODIES - A CONSENSUS VIEW, International journal of cancer, 1994, pp. 27-29
A RAPID AND HIGHLY SELECTIVE APPROACH TO CELL SEPARATIONS USING AN IMMUNOMAGNETIC COLLOID
Authors: HANCOCK JP KEMSHEAD JT
Citation: Jp. Hancock et Jt. Kemshead, A RAPID AND HIGHLY SELECTIVE APPROACH TO CELL SEPARATIONS USING AN IMMUNOMAGNETIC COLLOID, Journal of immunological methods, 164(1), 1993, pp. 51-60
VASE MINI-EXON USAGE BY NCAM IS NOT RESTRICTED TO TUMORS OF NEUROECTODERMAL ORIGIN
Authors: PATEL K CULVERWELL A ROSSELL RJ KEMSHEAD JT PHIMISTER E
Citation: K. Patel et al., VASE MINI-EXON USAGE BY NCAM IS NOT RESTRICTED TO TUMORS OF NEUROECTODERMAL ORIGIN, International journal of cancer, 54(5), 1993, pp. 772-777
Risultati: 1-17 |